Moffitt Cancer Center plans to build an ambulatory center in south Hillsborough County, making cancer care accessible to thousands of additional patients. Moffitt entered into a purchase and sale agreement of 9 acres in south Hillsborough County to build the center.
The WiTT Group and Mary Crowley Cancer Research form partership to enhance access to clinical trials
The WiTT Group Inc., a company focused on solving the non-clinical challenges patients face as they go through cancer treatment, formed a partnership Mary Crowley Cancer Research to identify and help patients gain access to clinical trials.
Sophia George was named the inaugural associate director of diversity, equity, and inclusion, and Ashish Shah was named director of clinical trials and translational research and principal investigator in the Section of Virology and Immunotherapy at Sylvester Comprehensive Cancer Center’s Brain Tumor Initiative at the University of Miami Miller School of Medicine.
The Sexual and Gender Minority Cancer Curricula to Advance Research & Education (SGM Cancer CARE) program is a three-day workshop and ten monthly seminars for early career professionals offered annually, at no cost to participants, over the next five years.
Nicholas Shungu was named associate director for diversity, equity, and inclusion at MUSC Hollings Cancer Center.
As she was interviewing for the director’s job at the George Washington Cancer Center, Julie E. Bauman was asked what her biggest fear would be.
In the next phase of the Cancer Moonshot, NCI will focus on investing in the development and testing of new modalities, including multi-cancer early detection assays, and fostering diversity in oncology, NCI Acting Director Douglas R. Lowy said at a joint meeting of the Board Of Scientific Advisors and the National Cancer Advisory Board.
Marquita Lewis-Thames, June McKoy, Jonathan Moreira, and Adam B. Murphy were named to leadership roles within the Robert H. Lurie Comprehensive Cancer Center of Northwestern University.
In a panel discussion this week, four cancer centers directors described how their experiences as immigrants have shaped their approach to oncology and the U.S. healthcare system.
After nearly five years in the federal government—at both NCI and FDA—Ned Sharpless is stepping down from his position as NCI director.
